Molecular Diagnostics
MicroRNA Profiling Shows Promise as Diagnostic and Prognostic Tool for Bladder Cancer
Profiling of 15 microRNAs from bladder tissue showed with 100% accuracy whether the cells were normal or malignant, while the determination of only two miRNAs could predict how well the patient would be able to defend against bladder cancer. More...28 Aug 2013
Gold Member
Collection and Transport System
PurSafe Plus®
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
In Other News
Gene Analysis Yields Markers for Non-Small-Cell Lung Cancer Death Risk
DNA Test Identifies Patients Risk of Statin Myopathy
Genetic Testing Introduced for Guiding Opioid Therapy
New Dual-Functional Fluorescent Probe for DNA Hybridization and Melting Point Analysis
Novel Molecular Assay Diagnoses Eight Gastrointestinal Parasites
Accurate Blood Test Discriminates Alzheimer's Disease
Low Expression of Immune Response Gene Increases TB Risk
Multitarget Assay Improves MRSA Screening
Gene Expression Profiles Define Microbial Infection
Gene Signature Determines Metastatic Behavior in Thymomas
Mutation Linked to Congenital Urinary Tract Defects
Portable Nucleic Acid Extraction System Developed For POC Diagnostics
Immunity Proteins Linked to Cancer
Molecular Subtyping Of Breast Cancer Shows Potential
Urine-Based Cancer Detection Technology Validated
Pioneering Method Rapidly Identifies Specific Pathogenic Strains
Genetic Cause of Rare Skin Disease Identified
Improved Molecular Diagnosis for Lynch Syndrome
New Molecular Diagnostic Test Detects Parvovirus B19
Gene Linked to Lymphatic Abnormalities
DNA Blood Test Identifies Serious Heart Problems
Genetic Tool Identifies Benign Thyroid Growths
First FDA-Approved Hepatitis C Genotyping Test Now Available
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
